Annick
Annick Arbellot De Vacqueur, Fontenay Les Briis FR
Patent application number | Description | Published |
---|---|---|
20080207720 | Novel Imidazolecarboxamide Derivatives as Fructose-1,6-Bisphosphatase Inhibitors, and Pharmaceutical Compositions Comprising Same - The invention relates to the compounds of the general formula (I): | 08-28-2008 |
20080312299 | Imidazole Derivatives as Fructose-1,6-Bisphosphatase Inhibitors and Pharmaceutical Compositions Containing Them - Imidazole derivatives of formula (I) wherein R | 12-18-2008 |
20100286129 | NOVEL BENZIMIDAZOLEDIHYDROTHIADIAZINONE DERIVATIVES AS FRUCTOSE-1,6-BISPHOSPHATASE INHIBITORS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME - The present invention relates to novel benzimidazole-dihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, to processes for the preparation thereof and to the use thereof in therapy, especially for the treatment of diabetes. | 11-11-2010 |
Annick Babeau-Garcia, Pessac FR
Patent application number | Description | Published |
---|---|---|
20120196337 | HETEROGENOUS ENZYMATIC CATALYST, PREPARATION METHOD, AND USE - The invention relates to a heterogenous enzymatic catalyst that takes the form of a cellular monolith consisting of a silica or organically modified silica matrix, said monolith including macropores, mesopores, and micropores, said pores being interconnected, and wherein the inner surface of the macropores is functionalized by a coupling agent selected from among silanes, said inner surface moreover having an unpurified enzyme attached thereon by means of a covalent or electrostatic bond. The invention also relates to the method for preparing said catalyst, said method comprising: a first step for preparing a solid silica impression that takes the form of a cellular monolith such as defined above; a second step for functionalizing the inner surface of the macropores via a coupling agent, selected from among silanes, by vacuum-soaking the cellular monolith by dissolving the coupling agent in an organic solvent; and a third step for vacuum-soaking the thus-functionalized monolith by means of an aqueous solution or aqueous dispersion of at least one unpurified enzyme. Finally, the invention relates to the use of such catalyst to carry out catalyzed chemical reactions. | 08-02-2012 |
Annick Bernalier, La Roche-Blanche FR
Patent application number | Description | Published |
---|---|---|
20100316617 | USE OF HYDROGENOTROPHIC ACETOGENIC STRAINS FOR PREVENTING OR TREATING DIGESTIVE DISORDERS - A method of modulating the microbial balance of the digestive ecosystem in a mammal comprising administering to a mammal in need thereof a composition comprising at least one nonpathogenic, hydrogenotrophic, acetogenic bacterial strain, along with a pharmaceutical and related methods, are described. | 12-16-2010 |
20120135957 | COMPOSITIONS CONTAINING MIXTURES OF FERMENTABLE FIBERS - The present invention relates to synergistic compositions comprising mixtures of fermentable fibers. The present invention specifically relates to composition comprising inulin and arabinoxylan for use in reducing, preventing and/or treating inflammation, wherein said arabinoxylan is partially hydrolyzed arabinoxylan and wherein the ratio of said inulin to said arabinoxylan and/or partially hydrolyzed arabinoxylan is between 65%/35% by weight and 90%/10% by weight. | 05-31-2012 |
Annick Datry, Paris FR
Patent application number | Description | Published |
---|---|---|
20120276577 | Method for Determining the Susceptibility of a Cell Strain to Drugs - The present invention relates to a method for determining the susceptibility of a cell strain to a compound intended for controlling the growth of said cell strain, comprising: | 11-01-2012 |
Annick De Poorter, Zele BE
Patent application number | Description | Published |
---|---|---|
20080200892 | Tampon - A tampon suitable for feminine hygiene and/or medical purposes having a longitudinal body provided with a dome-shaped insertion end and a withdrawal end, from which a withdrawal cord extends is disclosed. The tampon is made of compressed absorbent fibrous material and has an outer circumferential surface which is at least partially provided with longitudinal grooves that are separated from each other by longitudinal ribs. The path of the grooves and the ribs in the longitudinal direction of the tampon correspond to a continuous curved line that has only one point of inflection defining one convex part and one concave part, and that preferably does not show a maximum and/or a minimum. | 08-21-2008 |
20090024103 | TAMPON - A tampon suitable for feminine hygiene and/or medical purposes is disclosed having a longitudinal body provided with a dome-shaped insertion end and a withdrawal end, from which withdrawal end a withdrawal cord extends. The tampon has compressed absorbent fibrous material and has an outer circumferential surface which is at least partially provided with longitudinal grooves that are separated from each other by longitudinal ribs. The path of the grooves and ribs of the tampon in the longitudinal direction are inclined and correspond to a continuous curved line that has only one point of inflection defining one convex part and one concave part that preferably does not show a maximum or a minimum. | 01-22-2009 |
Annick Gargadennec, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20110046077 | PROCESS FOR THE EXTRACTION OF MANGIFERIN AND ISOMANGIFERIN - The present invention relates to methods for extracting and isolating glycosyl xanthone derivatives, in particular mangiferin and isomangiferin, from plants of the Rubiaceae family, especially of the | 02-24-2011 |
Annick Gascons, Charenton FR
Patent application number | Description | Published |
---|---|---|
20090188429 | Ring for holding a lens for dip treatment thereof - The ring comprises a hoop ( | 07-30-2009 |
20110070364 | METHOD FOR HOLDING A LENS FOR DIP TREATMENT THEREOF - Method for dip treatment of an optical element, wherein the optical element is held, while it is being dipped, by a holding ring, the ring including a hoop for draining and encircling a peripheral edge of the optical element, thereby exerting continuous linear contact with the peripheral edge, the hoop forming an arc over more than 180° and being provided at each of its two ends with an outwardly-directed drip tab pointing away from the optical element. | 03-24-2011 |
Annick Goergler, Colmar FR
Patent application number | Description | Published |
---|---|---|
20090029962 | 2-AZETIDINEMETHANEAMINES AND 2-PYRROLIDINEMETHANEAMINES AS TAAR-LIGANDS - The present invention relates to compounds of formula I | 01-29-2009 |
20100029589 | 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - The invention relates to compounds of formula I | 02-04-2010 |
20100041686 | 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - The invention relates to compounds of formula I | 02-18-2010 |
20110144333 | 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - The invention relates to compounds of formula I | 06-16-2011 |
20120165294 | 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - The invention relates to compounds of formula I | 06-28-2012 |
20130005988 | 2-AZETIDINEMETHANEAMINES AND 2-PYRROLIDINEMETHANEAMINES AS TAAR-LIGANDS - The present invention relates to compounds of formula I | 01-03-2013 |
20150045359 | MORPHOLINE COMPOUNDS AND USES THEREOF - The present invention relates to compounds of formula | 02-12-2015 |
Annick Harel-Bellan, Paris FR
Patent application number | Description | Published |
---|---|---|
20080287385 | Inhibitor oligonucleotides and their use for specific repression of a gene - A double-strand oligonucleotide including two complementary oligonucleotide sequences forming a hybrid, each including at one of their 3′ or 5′ ends, one to five unpaired nucleotides forming single-strand ends extending beyond the hybrid, one of the oligonucleotide sequences being substantially complementary to a target sequence belonging to a DNA or RNA molecule to be specifically repressed, the target sequence belonging to a DNA or RNA molecule of a gene coding an angiogenic factor. | 11-20-2008 |
20090053718 | NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs - The invention relates to ribonucleic acids and oligonucleotide probes useful for detection and analysis of microRNAs and their target mRNAs, as well as small interfering RNAs (siRNAs). The invention furthermore relates to oligonucleotide probes for detection and analysis of other non-coding RNAs, mRNAs, mRNA splice variants, allelic variants of single transcripts, mutations, deletions, or duplications of particular exons in transcripts, e.g. alterations associated with human disease, such as cancer. | 02-26-2009 |
20130281313 | PROGNOSTIC AND/OR PREDICTIVE BIOMARKERS AND BIOLOGICAL APPLICATIONS THEREOF - The present invention relates to the fields of genetics, immunology and medicine. The present invention more specifically relates to the identification of human genes and expression products thereof which can be used to assess the prognosis of a cancer in a subject, to assess the sensitivity of a subject to a treatment of cancer, or monitor, in particular determine the efficacy, of such a treatment of cancer after a given period of time. Said human genes and expression products can further be used (i) in the prevention or treatment of cancer, in particular to determine or select the appropriate cancer treatment for a given subject and/or for a particular tumor, as well as (ii) for the screening of therapeutically active drugs. Particular compounds capable to compensate, in a subject, an abnormal expression of one of the herein described products, in particular when the subject is exposed to a therapeutic treatment of cancer, thereby allowing or improving its efficiency in the subject, are also herein disclosed. Inventors, in addition, provide kits and DNA chips usable in the context of the present invention. | 10-24-2013 |
Annick Libotte, Nivelles BE
Patent application number | Description | Published |
---|---|---|
20140037946 | LAMINATE COMPRISING A POLYOLEFIN LAYER ADHERED TO A BASE LAYER - A laminate is disclosed comprising a polyolefin layer of a composition comprising a blend of 90-99.7 wt % of a copolymer of propylene and at least one α-olefin, and 0.3-10 wt % of a polyethylene having a density of 940 kg/m | 02-06-2014 |
Annick Ludwig, Wilrijk BE
Patent application number | Description | Published |
---|---|---|
20160114048 | THERMOLABILE DRUG RELEASE FORMULATION - The present invention relates to a drug release formulation, in particular a sustained release formulation for ophthalmic applications and a method of preparing same. The method is based on the hydration of a given solid polymeric matrix material under mild conditions, allowing versatility with respect to the drug to be formulated. Both said solid polymeric matrix material as well the API hydrated formulation is an object of the present invention. The thus obtained material is particularly suitable for prolonged and sustained delivery of medication to the eye. Thus in a further aspect, the present invention provides the use of said solid polymeric matrix material as well the API hydrated formulation, in ophthalmic applications. | 04-28-2016 |
Annick Mercenier, Bussigny CH
Patent application number | Description | Published |
---|---|---|
20120021078 | NUTRITIONAL COMPOSITION COMPRISING AN APPLE EXTRACT AND REDUCING FOOD ALLERGY SYMPTOMS, ESPECIALLY IN CHILDREN - A complete nutritional composition comprising polyphenols is provided for reducing the symptoms of allergies originating from food allergens in young children or infants. Preferably the composition modulates the secondary prevention of allergies while not affecting significantly the primary prevention. The composition comprises an apple extract. | 01-26-2012 |
20120064051 | INFANT AND YOUNG CHILDREN FEEDING FORMULA COMPRISING PROBIOTICS FOR INFANTS AND YOUNG CHILDREN - The present invention relates to the field of infant and young children nutrition. In particular, the present invention relates to infant and young children feeding formulas comprising probiotic micro-organisms to be administered to infants and young children older than 6 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | 03-15-2012 |
20120107287 | SPECIALIZED MEDICAL NUTRITION FOR SURGICAL AND TRAUMA PATIENTS CONTAINING PROBIOTICS - The present invention relates to the field of specialized nutritional compositions. In particular, the present invention provides nutritional compositions for providing complete nutrition to hospitalized patients comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | 05-03-2012 |
20120107290 | NON-REPLICATING MICRO-ORGANISMS AND THEIR IMMUNE BOOSTING EFFECT - The present invention generally relates to the field of probiotic bacteria. In particular, the present invention conceras non-replicating probiotics, such as the genus Lactobacillus, Bifidobacterium or combinations thereof, for example | 05-03-2012 |
20120114701 | BIFIDOBACTERIUM LONGUM NCC2705 (CNCM I-2618) AND IMMUNE DISORDERS - The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of | 05-10-2012 |
20120121561 | DRY WHOLE MILK PREPARATIONS CONTAINING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of nutrition for young children. In particular, the present invention relates to dry whole milk preparations comprising probiotic micro-organisms to be administered to young children older than 12 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | 05-17-2012 |
20120121563 | SPECIALIZED NUTRITIONAL FORMULA FOR ADULT PATIENTS WITH GASTROINTESTINAL INTOLERANCE CONTAINING PROBIOTICS - The present invention relates to the field of nutrition for adults. In particular, the present invention relates to the nutritional compositions intended for adults with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to adults with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. | 05-17-2012 |
20120121652 | COMPLETE LIQUID NUTRITION FOR CHILDREN AT THE AGE OF 1-10 YEARS COMPRISING PROBIOTICS - The present invention relates to the field of nutrition for children. In particular, the present invention relates to the nutritional compositions intended for children with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to children with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. | 05-17-2012 |
20120121685 | BREAKFAST CEREALS CONTAINING PROBIOTIC MICRO ORGANISMS - The present invention relates to the field of nutrition. In particular, the present invention relates to a breakfast cereal composition comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | 05-17-2012 |
20120128726 | INFANT FEEDING FORMULAS COMPRISING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of infant nutrition. In particular, the present invention relates to infant feeding formulas comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | 05-24-2012 |
20120135044 | INSTANT THICKENER COMPRISING PROBIOTICS FOR HOT OR COLD FOODS AND BEVERAGES TO BE ADMINISTERED TO DYSPHAGIC PATIENTS - The present invention relates to the fields of hydration and nutrition for dysphagic patients. In particular, the present invention relates to thickeners comprising probiotic microorganisms and to compositions comprising such thickeners. The probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic microorganisms. | 05-31-2012 |
20120141443 | SHORT-TIME HIGH TEMPERATURE TREATMENT GENERATES MICROBIAL PREPARATIONS WITH ANTI-INFLAMMATORY PROFILES - The present invention generally relates to the field of bacteria. In particular, the present invention concerns “short time high temperature” treated probiotics and/or dairy starter cultures and applications of these bacteria. One embodiment of the present invention relates to “short-time high temperature” treated probiotics and/or dairy starter cultures and their use to prepare compositions to treat or prevent inflammatory disorders. | 06-07-2012 |
20120141444 | NUTRITIONALLY BALANCED STANDARD TUBE FEEDING FORMULA CONTAINING PROBIOTICS - The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding formulas for complete nutrition comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | 06-07-2012 |
20120148629 | NUTRITIONAL COMPOSITION COMPRISING LACTOCOCCUS STRAINS AND REDUCING ALLERGY SYMPTOMS, ESPECIALLY IN INFANTS AND CHILDREN - A complete nutritional composition comprising | 06-14-2012 |
20120164109 | NUTRITIONAL COMPOSITION COMPRISING BIFIDOBACTERIUM LONGUM STRAINS AND REDUCING FOOD ALLERGY SYMPTOMS, ESPECIALLY IN INFANTS AND CHILDREN - A complete nutritional composition comprising | 06-28-2012 |
20120183506 | PREVENTION AND TREATMENT OF ALLERGIC DIARRHOEA - This invention relates to | 07-19-2012 |
20120183514 | INFANT CEREAL COMPRISING NON-REPLICATING PROBIOTIC MICROORGANISMS - The present invention relates to the field of infant cereals. In particular, the present invention relates to the field of infant cereals that can be used to strengthen the immune system of the infant and/or that can be used to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to an infant cereal comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms. | 07-19-2012 |
20120183515 | ORAL NUTRITIONAL SUPPLEMENT COMPRISING PROBIOTICS - The present invention relates to the field of nutrition. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics. | 07-19-2012 |
20120189598 | ORAL NUTRITIONAL SUPPLEMENT FOR CHILDREN COMPRISING PROBIOTICS - The present invention relates to the field of nutrition for children. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics. | 07-26-2012 |
20120195867 | PROBIOTIC CONTAINING MODULES FOR TUBE FEEDING - The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding modules comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | 08-02-2012 |
20120269789 | GROWING UP MILKS CONTAINING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of nutrition for infants and young children. In particular, the present invention relates to growing-up milks comprising probiotic micro-organisms to be administered to infants and young children older than 10 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | 10-25-2012 |
20130028877 | LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS - The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of non-replicating | 01-31-2013 |
20130165374 | PREVENTION OF ALLERGY AT WEANING - A nutritional composition comprising a partially hydrolysed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-β per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed. | 06-27-2013 |
20130224165 | DRINKING YOGHURT PREPARATIONS CONTAINING NON-REPLICATING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of drinkable yoghurt compositions. In particular, the present invention provides drinkable yoghurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may be bioactive heat treated probiotic micro-organisms, for example. The present invention also relates to health benefits provided by these non-replicating probiotic micro-organisms. | 08-29-2013 |
20130224166 | POWDERED CEREAL COMPOSITIONS COMPRISING NON-REPLICATING PROBIOTIC MICROORGANISMS - The present invention relates to the field of powdered cereal compositions to be reconstituted in milk, infant formula or water. In particular, the present invention relates to powdered cereal compositions to be administered to infants or young children. The powdered cereal compositions may be used to strengthen the immune system and/or to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to a powdered cereal composition comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms. | 08-29-2013 |
20130224167 | NON-REPLICATING PROBIOTIC BACTERIA AND PREVENTION OR TREATMENT OF INFECTIONS TO REDUCE ABSENCE FROM SCHOOL OR DAYCARE - The present invention relates to non-replicating probiotic micro-organisms and their health benefits. In particular, the present invention provides a means to help parents to protect their children from infections. The subject matter of the present inventions allows it to reduce absence from school or daycare. One embodiment of the present invention relates to a composition comprising non-replicating probiotic micro-organisms for use in the prevention or treatment of infections in children to reduce absence from school or daycare. | 08-29-2013 |
20130224253 | NON-REPLICATING PROBIOTIC MICRO-ORGANISMS PROTECT AGAINST UPPER RESPIRATORY TRACT INFECTIONS - The present invention relates to non-replicating probiotic micro-organisms and their health benefits. For example, the present invention relates to compositions comprising non-replicating probiotic micro-organisms for use in the treatment of prevention of upper respiratory tract infections and/or their symptoms. Embodiments of the present invention provide means to help parents to protect their children from such upper respiratory tract infections. | 08-29-2013 |
20130224254 | NON-REPLICATING PROBIOTIC MICRO-ORGANISMS PROTECT CHILDREN AGAINST GASTROINTESTINAL INFECTIONS - The present invention relates to non-replicating probiotic micro-organisms and their health benefits. In particular, the present invention provides a means to help parents to protect their children from gastro-intestinal infections, in particular diarrhea. One embodiment of the present invention relates to a composition comprising non-replicating probiotic micro-organisms for use in the prevention or treatment of gastrointestinal infections in children. | 08-29-2013 |
20130230611 | EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS - The present invention generally relates to the field of probiotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic micro-organisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system. | 09-05-2013 |
20130236581 | FROZEN CONFECTIONS CONTAINING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of frozen yoghurt. In particular, the present invention provides frozen yoghurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may bioactive heat treated probiotic micro-organisms, for example. The present inventions also relates to health benefits provided by these non-replicating probiotic micro-organisms. | 09-12-2013 |
20130260440 | BIFIDOBACTERIUM LONGUM NCC2705 (CNCM I-2618) AND IMMUNE DISORDERS - The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of | 10-03-2013 |
20130287874 | SPOONABLE YOGURT PREPARATIONS CONTAINING NON-REPLICATING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of spoonable yogurt compositions. In particular, the present invention provides spoonable yogurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may be bioactive heat treated probiotic micro-organisms, for example. The present invention also relates to health benefits provided by these non-replicating probiotic micro-organisms. | 10-31-2013 |
20130309357 | PET FOOD PREPARATIONS CONTAINING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of pet food. In particular, the present invention provides pet food compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may be bioactive heat treated probiotic micro-organisms, for example. The present inventions also relates to health benefits provided by these non-replicating probiotic micro-organisms. | 11-21-2013 |
20140004152 | MILK-BASED PROTEIN HYDROLYSATES AND INFANT FORMULAE AND NUTRITIONAL COMPOSITIONS MADE THEREOF | 01-02-2014 |
20140023669 | USE OF A HYPOALLERGENIC CEREAL COMPOSITION FOR INDUCING SPECIFIC ORAL TOLERANCE - A partial hydrolysate of cereal protein for use in inducing specific oral tolerance in a young mammal with allergy to said cereal protein, wherein the hydrolysate has a degree of hydrolysis between 9 and 18%, is disclosed. | 01-23-2014 |
20140037686 | LACTOBACILLUS PARACASEI NCC2461 (ST11) FOR USE BY PERINATAL MATERNAL ADMINISTRATION IN THE REDUCTION AND PREVENTION OF ALLERGIES IN PROGENY - The present invention provides a probiotic, | 02-06-2014 |
20140170126 | PROBIOTIC FOR ADMINISTRATION TO HEALTHY YOUNG MAMMALS DURING THE WEANING PERIOD FOR IMPROVING TOLERANCE TO NEWLY INTRODUCED FOOD STUFFS - The current invention is based upon administration of a probiotic, | 06-19-2014 |
20140193534 | EPICATECHIN FOR ALLEVIATING SYMPTOMS OF ALLERGY - The present invention relates to epicatechin for use in the prevention or reduction of symptoms of an allergic disorder and/or an allergic reaction. The invention further relates to epicatechin for said use in the form of food, food product, food supplement or pharmaceutical products. | 07-10-2014 |
20150017143 | COMPOSITION COMPRISING SPECIFIC LACTOBACILLUS HELVETICUS STRAINS AND REDUCING FOOD AND/OR RESPIRATORY ALLERGY SYMPTOMS - A composition comprising specific | 01-15-2015 |
20150072033 | EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS - The present invention generally relates to the field of pro biotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system. | 03-12-2015 |
20150079056 | INFANT CEREAL COMPRISING NON-REPLICATING PROBIOTIC MICROORGANISMS - The present invention relates to the field of infant cereals. In particular, the present invention relates to the field of infant cereals that can be used to strengthen the immune system of the infant and/or that can be used to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to an infant cereal comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms. | 03-19-2015 |
20150290140 | COMPOSITIONS COMPRISING MICROPARTICLES AND PROBIOTICS TO DELIVER A SYNERGISTIC IMMUNE EFFECT - Microparticulate compositions and nutritional compositions containing the microparticulate compositions are disclosed herein. In a general embodiment, the microparticulate compositions include one or more probiotics and have a size ranging from about micron to about 20 microns. The microparticulate compositions can be added to any suitable nutritional composition. | 10-15-2015 |
20150297506 | USE OF PROBIOTIC MICRO-ORGANISMS AS AN AGENT THAT PROMOTES THE SYNTHESIS OF MELANIN - The present invention relates to the oral use of | 10-22-2015 |
20150343002 | USE OF PROBIOTIC MICRO-ORGANISMS AS AN AGENT THAT PROMOTES THE SYNTHESIS OF MELANIN - The present invention relates to the topical use of | 12-03-2015 |
Annick Mercenier, Epalinges CH
Patent application number | Description | Published |
---|---|---|
20090274661 | USE OF BIFIDOBACTERIUM LONGUM FOR THE PREVENTION AND TREATMENT OF INFLAMMATION - The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of | 11-05-2009 |
20100322964 | BACTERIAL COMPOSITION AND ITS USE - The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of | 12-23-2010 |
20110021428 | PREVENTION OF ALLERGY AT WEANING - A nutritional composition comprising a partially hydrolysed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-β per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed. | 01-27-2011 |
20120135036 | BACTERIAL COMPOSITION AND ITS USE - The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of | 05-31-2012 |
20120201785 | USE OF BIFIDOBACTERIUM LONGUM FOR THE PREVENTION AND TREATMENT OF INFLAMMATION - The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of | 08-09-2012 |
20150079041 | BACTERIAL COMPOSITION AND ITS USE - The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of | 03-19-2015 |
Annick Ocmant, Le Roeulx BE
Patent application number | Description | Published |
---|---|---|
20100129788 | METHOD FOR EVALUATING THE RESPONSE OF AN INDIVIDUAL TO A TREATMENT WITH A TYPE I INTERFERON (IFN) - A method for evaluating the in vivo presence of a factor that prevents the biological effect of a type I (IFN) in an individual that is under treatment with type I interferon is described. The in vivo presence of antibodies directed against a type I interferon (IFN) is evaluated in an individual that is under treatment with type I interferon. The method includes incubating a blood sample of the individual in vitro with a suitable amount of the type I interferon for a suitable period of time, and determining mRNA levels of a biological marker of IFN activity, preferably M×A, in the blood sample. The treatment may involve a treatment of multiple sclerosis, HCV or HBV using a type I interferon. | 05-27-2010 |
20120190031 | MARKER FOR DIAGNOSIS OF ACTIVE MULTIPLE SCLEROSIS - The invention provides an improved method for monitoring the course of the MS disease and to predict, diagnose or prognosticate whether a subject is in an active or non-active period of MS. The method is based on determining the ratio of the expression levels of two cytokines, measured before and after stimulation of the subject by an immunomodulator. | 07-26-2012 |
Annick Poliszczak, Rixensart BE
Patent application number | Description | Published |
---|---|---|
20090130145 | VACCINE - The invention provides an attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7. The invention particularly provides a rotavirus population designated as P43. The invention further provides a novel formulation for a rotavirus vaccine which is in the form of a quick dissolving tablet for immediate dissolution when placed on the tongue. | 05-21-2009 |
20090170066 | METHODS AND MATERIALS THEREFOR - The present invention relates to a method for detecting or detecting and identifying rotavirus in a biological sample. In particular, the invention relates to a detection method comprising contacting the nucleic acids from the sample or derived from the sample with at least one VP4 and/or VP7 universal probes in the context of a solid support and detecting any type-specific hybridisation. The invention further relates to a detection or detection followed by typing method comprising contacting the nucleic acids from the sample or derived from the sample with at least one P type-specific and G type-specific probes in the context of a solid support and detecting any type-specific hybridisation. The invention also relates to primers and probes used therein and to diagnostic kits. | 07-02-2009 |
Annick Pucci, Croissy-Sur-Seine FR
Patent application number | Description | Published |
---|---|---|
20080223753 | METHOD FOR DESULFURIZING HYDROCARBON FRACTIONS FROM STEAM CRACKING EFFLUENTS - The present invention relates to a method for treating a feed corresponding to a pyrolysis gasoline, comprising: | 09-18-2008 |
20090101545 | Method for Desulfurising Olefin Motor Gasoline - The invention concerns a process for producing gasoline with a low sulphur content and a controlled olefins content, comprising a step for oligomerizing an olefinic feed (step i), a step ii) consisting of mixing the branched olefinic gasoline produced in step i) with a gasoline rich in sulphur and olefins, a step iii) for hydrodesulphurization of said mixture, and separating the H | 04-23-2009 |
20110114538 | PROCESS FOR THE PRODUCTION OF HIGH-QUALITY KEROSENE AND DIESEL FUELS FOR THE COPRODUCTION OF HYDROGEN FROM SATURATED LIGHT CUTS - Process mainly for the production of high-quality kerosene and diesel fuels and for the coproduction of hydrogen from a so-called light naphtha cut to which any quantity of LPG cut can be added, employing the following successive stages: dehydrogenation of the paraffins, oligomerization of the olefins and hydrogenation of the oligomerized olefins, the process permitting the production of kerosene and diesel fuels meeting market specifications, or even improved relative to the latter. | 05-19-2011 |
20120103867 | PROCESS FOR THE PRODUCTION OF KEROSENE AND DIESEL FUELS FROM LIGHT UNSATURATED FRACTIONS AND BTX-RICH AROMATIC FRACTIONS - Process for the production of kerosene and diesel fuels from a so-called light cracked naphtha fraction, to which can be added any quantity of an LPG fraction and a BTX-rich aromatic fraction and which uses a stage for oligomerization of olefins and alkylation of olefins on the aromatic compounds. | 05-03-2012 |
20130211161 | PROCESS FOR CONVERTING A HEAVY FEED USING A CATALYTIC CRACKING UNIT AND A STEP FOR SELECTIVE HYDROGENATION OF THE GASOLINE OBTAINED FROM CATALYTIC CRACKING - The present invention describes a process for converting a heavy feed which is flexible for the production of propylene, gasoline and middle distillate. | 08-15-2013 |
20130225897 | PROCESS FOR ELIMINATION OF MERCURY CONTAINED IN A HYDROCARBON FEED WITH HYDROGEN RECYCLING - Elimination of mercury contained in a hydrocarbon feed by: | 08-29-2013 |
20140374315 | PROCESS FOR PRODUCING A GASOLINE WITH A LOW SULPHUR AND MERCAPTANS CONTENT - The present application concerns a process for the treatment of a gasoline containing sulphur-containing compounds and olefins, with the following steps: | 12-25-2014 |
20140374321 | PROCESS FOR ELIMINATING ARSENIC FROM A HYDROCARBON FEED - The invention concerns a process for eliminating arsenic from a hydrocarbon feed which is at least partially liquid, comprising at least the following steps: | 12-25-2014 |
20160075955 | PROCESS FOR HYDROGENATION OF A HYDROCARBON FEEDSTOCK COMPRISING AROMATIC COMPOUNDS - Process for hydrogenation of aromatic compounds in a feedstock comprising hydrocarbons having at least five carbon atoms, comprising: | 03-17-2016 |
Annick Sauger, Les Ulis FR
Patent application number | Description | Published |
---|---|---|
20110250702 | ISOLATED PEPTIDES OF RABBIT FACTOR VII - The present disclosure relates to peptides isolated from rabbit factor VII and to the use of thereof for the generation of antibodies specifically directed against the latter. The disclosure also relates to the use of antibodies directed against rabbit factor VII for the detection or purification of rabbit factor VII, specifically when said rabbit factor VII is in a biological sample which also contains human factor VII. | 10-13-2011 |
Annick Stote, Strasbourg FR
Patent application number | Description | Published |
---|---|---|
20140287989 | Compounds Binding to the Bacterial Beta Ring - The present invention relates to compounds which bind to the hydrophobic pocket of the β clamp, i.e., to the surface of the β ring with which said protein interacts with other proteins of the bacterial replication complex during DNA replication. These compounds are derived from the acetylated peptide AcQLDLF (P6) to improve their affinity to their target. | 09-25-2014 |
Annick Tibi, Charenton FR
Patent application number | Description | Published |
---|---|---|
20150224070 | Gelling Formulation Containing Ketamine - A gelling formulation containing ketamine or a pharmaceutically acceptable salt thereof in water, a poloxamer and one or more pharmaceutically acceptable mucoadhesive agents is provided. Also provided is a method of using the formulation for pain treatment. | 08-13-2015 |
Annick Vandercammen, Rixensart BE
Patent application number | Description | Published |
---|---|---|
20110311577 | METHOD OF PRODUCING A VACCINE - The present invention relates to a method for purifying bacterial cytolysins such as pneumococcal pneumolysin. A single chromatography step produces excellent purification of the cytolysin by binding soluble aggregated cytolysin to a hydrophobic interaction chromatography material in the presence of detergent and high salt. | 12-22-2011 |
20140010843 | METHOD OF DETOXIFICATION - The present invention relates to a method of detoxifying bacterial cytolysins such as pneumococcal pneumolysin, utilizing chemical cross-linking compounds. | 01-09-2014 |
Annick Vanhulsel, Begijnendijk BE
Patent application number | Description | Published |
---|---|---|
20110223351 | LASER CLADDING OF A THERMOPLASTIC POWDER ON PLASTICS - A method applies a coating ( | 09-15-2011 |
Annick Vassout, Sierentz FR
Patent application number | Description | Published |
---|---|---|
20080306081 | Combinations of Nicotinic Acetylcholine Alpha 7 Receptor Antagonists - Combinations which comprise at least one nicotinic acetylcholine alpha 7 receptor agonist and at least one compound selected from the group consisting of (a) conventional antipsychotics (b) atypical antipsychotics (c) cognition, attention and/or memory enhancers (d) and to use of these combinations in the treatment of psychiatric disorders. | 12-11-2008 |
20100063029 | USE OF S-10-HYDROXY-10,11-DIHYDRO-CARBAMAZEPINE FOR THE TREATMENT OF ANXIETY AND BIPOLAR DISORDERS - The present invention relates to the use of a racemate of the compound of formula (I) consisting of at least 85% S-enantiomer and not more than 15% R-enantiomer or of pharmaceutically acceptable salts of said racemate or of the S-enantiomer of formula I or of pharmaceutically acceptable salts of said anantiomer for the treatment of anxiety or other psychiatric disorders with underlying anxiety symptomatologies or for the treatment of affective and attention disorders; pharmaceutical compositions for that purpose and packages comprising said pharmaceutical compositions together with instructions for the use of said compositions for the treatment of anxiety or other psychiatric disorders with underlying anxiety symptomatologies or of affective and attention disorders. | 03-11-2010 |
20100125063 | COMBINATIONS OF NICOTINIC ACETYLCHOLINE ALPHA 7 RECEPTOR AGONISTS - Combinations which comprise at least one nicotinic acetylcholine alpha 7 receptor agonist and at least one compound selected from the group consisting of (a) conventional antipsychotics (b) atypical antipsychotics (c) cognition, attention and/or memory enhancers (d) and to use of these combinations in the treatment of psychiatric disorders. | 05-20-2010 |